Cytrellis Biosystems, Inc.

Cytrellis, Inc. is a Massachusetts-based medical technology company focused on developing innovative aesthetic devices that address sagging skin associated with aging. The company is known for its flagship product, the ellacor® System with Micro-Coring® Technology, which is an FDA-cleared device designed to provide a non-surgical, scar-free solution for skin rejuvenation. This technology allows for precise treatment of age-related skin laxity and has received additional regulatory approvals from Health Canada and the Saudi Food and Drug Authority. Founded in the Boston/Woburn area, Cytrellis collaborates with leading dermatologists and plastic surgeons to ensure safety and clinical efficacy. The company has successfully raised significant funding to support its growth and innovation. With a strong emphasis on accountability, customer-centricity, and data-driven decisions, Cytrellis is committed to advancing aesthetic medical devices while fostering a culture of empowerment and fun within its team.